Antioxidant therapy in critical care - Is the microcirculation the primary target?

Critical Care Medicine

Volumn 35, Issue 9 SUPPL., 2007, Pages

  Biesalski, Hans Konrad ^a   McGregor, Gerard Patrick ^b  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Antioxidant therapy; Ascorbate; Endothelial dysfunction; Multiple organ failure; Oxidative stress; Parenteral vitamin C; Severe burn; Systemic inflammatory response syndrome

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SELENIUM;

ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; BURN; CARDIOGENIC SHOCK; CARDIOVASCULAR SYSTEM; CONFERENCE PAPER; CRITICALLY ILL PATIENT; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; FLUID BALANCE; HEMODYNAMICS; HUMAN; INFLAMMATION; INJURY; INTENSIVE CARE; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESUSCITATION; SEPSIS; SEPTIC SHOCK;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; OXIDATIVE STRESS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASODILATION; VITAMINS; WOUNDS AND INJURIES;

EID: 34548168375     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000278598.95294.C5     Document Type: Conference Paper

References (63)

1. Potdar PD, Kandarkar SV, Sirsat SM: Modulation by vitamin C of tumour incidence and inhibition in oral carcinogenesis. Funct Dev Morphol 1992; 2:167-172
2. Sibbald W: Shockingly complex: The difficult road to introducing new ideas to critical care. Crit Care 2004; 8:419-421
3. Matsuda N, Hattori Y: Systemic inflammatory response syndrome (SIRS): Molecular pathophysiology and gene therapy. J Pharmacol Sci 2006; 101:189-198
4. Mishra V: Oxidative stress and role of antioxidant supplementation in critical illness. Clin Lab 2007; 53:199-209
5. Bulger EM, Maier RV: Antioxidants in critical illness. Arch Surg 2001; 136:1201-1207
6. Berger MM: Antioxidant micronutrients in major trauma and burns: Evidence and practice. Nutr Clin Pract 2006; 21:438-449
7. Crimi E, Sica V, Williams-Ignarro S, et al: The role of oxidative stress in adult critical care. Free Radic Biol Med 2006; 40:398-406
8. Heyland DK, Dhaliwal R, Day AG, et al: Reducing Deaths due to OXidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 2006; 65:250-263
9. Alonso de Vega JM, Diaz J, Serrano E, et al: Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002; 30:1782-1786
10. Goodyear-Bruch C, Pierce JD: Oxidative stress in critically ill patients. Am J Crit Care 2002; 11:543-551
11. Goode HF, Cowley HC, Walker BE, et al: Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23:646-651
12. Galley HF, Davies MJ, Webster NR: Ascorbyl radical formation in patients with sepsis: Effect of ascorbate loading. Free Radic Biol Med 1996; 20:139-143
13. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765-77
14. Volk T, Kox WJ: Endothelium function in sepsis. Inflamm Res 2000; 49:185-198
15. Levine M, Conry-Cantilena C, Wang Y, et al: Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 1996; 93:3704-3709
16. Harrison DG: Endothelial function and oxidant stress. Clin Cardiol 1997; 20:II-11-II-7
17. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000; 87:840-844
18. Lunec J, Blake DR: The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA). Free Radic Res Commun 1985; 1:31-39
19. Schorah CJ, Downing C, Piripitsi A, et al: Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996; 63:760-765
20. Kelly G: The interaction of cigarette smoking and antioxidants. Part III: Ascorbic acid. Altern Med Rev 2003; 8:43-54
21. del Rincon ID, Williams K, Stern MP, et al: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44:2737-2745
22. Frei B: On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 1999; 222:196-204
23. May JM: How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 2000; 28:1421-1429
24. Long CL, Maull KI, Krishnan RS, et al: Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003; 109:144-148
25. Nathens AB, Neff MJ, Jurkovich GJ, et al: Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236:814-822
26. Metnitz PG, Bartens C, Fischer M, et al: Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999; 25:180-185
27. Du WD, Yuan ZR, Sun J, et al: Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms. World J Gastroenterol 2003; 9:2565-2569
28. Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101:1899-1906
29. Widlansky ME, Gokce N, Keaney JF Jr, et al: The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42:1149-1160
30. Heitzer T, Just H, Munzel T: Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996; 94:6-9
31. Rossig L, Hoffmann J, Hugel B, et al: Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 2001; 104:2182-2187
32. Heitzer T, Schlinzig T, Krohn K, et al: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104:2673-2678
33. Baker TA, Milstien S, Katusic ZS: Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 2001; 37:333-338
34. Kuzkaya N, Weissmann N, Harrison DG, et al: Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid and thiols: Implications for uncoupling endothelial nitric oxide synthase. J Biol Chem 2003; 278:22546-22554
35. Jackson TS, Xu A, Vita JA, et al: Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998; 83:916-922
36. Jourd'heuil D, Jourd'heuil FL, Kutchukian PS, et al: Reaction of superoxide and nitric oxide with peroxynitrite: Implications for peroxynitrite-mediated oxidation reactions in vivo. J Biol Chem 2001; 276:28799-28805
37. Demiryurek AT, Cakici I, Kanzik I: Peroxynitrite: A putative cytotoxin. Pharmacol Toxicol 1998; 82:113-117
38. Carr A, Frei B: The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic Biol Med 2000; 28:1806-1814
39. Armour J, Tyml K, Lidington D, et al: Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol 2001; 90:795-803
40. Wu F, Tyml K, Wilson JX: Ascorbate inhibits iNOS expression in endotoxin- and IFN gamma-stimulated rat skeletal muscle endothelial cells. FEBS Lett 2002; 520:122-126
41. Nualart FJ, Rivas CI, Montecinos VP, et al: Recycling of vitamin C by a bystander effect. J Biol Chem 2003; 278:10128-10133
42. Parratt JR: Nitric oxide in sepsis and endotoxemia. J Antimicrob Chemother 1998; 41:31-39
43. Levenson SM, Green RW, Taylor FHL, et al: Ascorbic acid, riboflavin, thiamin, and nicotinic acid in relation to severe injury, hemorrhage, and infection in the human. Ann Surg 1946; 124:840-856
44. Crandon JH, Landau B, Mikal S, et al: Ascorbic acid economy in surgical patients as indicated by blood ascorbic acid levels. N Engl J Med 1958; 258:105-113
45. Du CB, Liu JW, Su W, et al: The protective effect of ascorbic acid derivative on PC12 cells: involvement of its ROS scavenging ability. Life Sci 2003; 74:771-780
46. Cowley HC, Bacon PJ, Goode HF, et al: Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors. Crit Care Med 1996; 24:1179-1183
47. Pleiner J, Mittermayer F, Schaller G, et al: High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation 2002; 106:1460-1464
48. Pleiner J, Mittermayer F, Schaller G, et al: Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. J Am Coll Cardiol 2003; 42:1656-1662
49. Macarthur H, Westfall TC, Riley DP, et al: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A 2000; 97:9753-9758
50. Tyml K, Li F, Wilson JX: Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle. Crit Care Med 2005; 33:1823-1828
51. Lehmann C, Usichenko TI, Pavlovic D: From scurvy to sepsis: Vitamin C - A pill for all seasons? Crit Care Med 2005; 33:1881-1882
52. Monafo WW: Initial management of burns. N Engl J Med 1996; 335:1581-1586
53. Matsuda T, Tanaka H, Hanumadass M, et al: Effects of high-dose vitamin C administration on postburn microvascular fluid and protein flux. J Burn Care Rehabil 1992; 13:560-566
54. Cetinkale O, Belce A, Konukoglu D, et al: Evaluation of lipid peroxidation and total antioxidant status in plasma of rats following thermal injury. Burns 1997; 23:114-116
55. Bertin-Maghit M, Goudable J, Dalmas E, et al: Time course of oxidative stress after major burns. Intensive Care Med 2000; 26: 800-803
56. Pintaudi AM, Tesoriere L, D'Arpa N, et al: Oxidative stress after moderate to extensive burning in humans. Free Radic Res 2000; 33:139-146
57. Horton JW: Free radicals and lipid peroxidation mediated injury in burn trauma: The role of antioxidant therapy. Toxicology 2003; 189:75-88
58. Fujimoto M, Uemura M, Nakatani Y, et al: Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: Relation to severity of liver disturbance. Alcohol Clin Exp Res 2000; 24:48S-54S
59. Dubick MA, Williams C, Elgjo GI, et al: High-dose vitamin C infusion reduces fluid requirements in the resuscitation of burn-injured sheep. Shock 2005; 24:139-144
60. Tanaka H, Matsuda T, Miyagantani Y, et al: Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: A randomized, prospective study. Arch Surg 2000; 135:326-331
61. Buttke TM, Sandstrom PA: Redox regulation of programmed cell death in lymphocytes. Free Radic Res 1995; 22:389-397
62. Valko M, Morris H, Cronin MT: Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12:1161-208
63. McGregor GP, Biesalski HK: Rationale and impact of vitamin C in clinical nutrition. Curr Opin Clin Nutr Metab Care 2006; 9:697-703